Literature DB >> 30643771

Liver Imaging Techniques: Recognition of Uveal Melanoma Metastases.

Claudine Bellerive1, Etienne Ouellet2, Aya Kamaya2, Arun D Singh1.   

Abstract

BACKGROUND: The liver is the most common site for metastases of several primary malignancies including uveal melanoma.
METHODS: Review of imaging characteristics of incidental common benign liver lesions including hepatic cyst, hemangioma, focal nodular hyperplasia, and hepatic adenoma and contrasting them with uveal melanoma metastases.
RESULTS: Benign hepatic lesions may be cystic or, if solid, relatively stable in size over time. For hepatic lesions larger than 10 mm in size, characteristic imaging features typically allow for confident diagnosis. When lesions are small (less than 10 mm), definitive characterization can be difficult. Moreover, lesions smaller than 10 mm can be difficult to biopsy under ultrasound or computed tomography (CT) guidance, and short-term follow-up will often be useful to assess for stability or progression. Overall, magnetic resonance imaging is more specific than CT scan and at least as sensitive as CT for detecting uveal melanoma liver metastases.
CONCLUSIONS: New multiple enhancing solid liver lesions should raise suspicion of uveal melanoma liver metastases. Discussion of challenging cases with the radiologist may be beneficial, as pertinent information such as size, location, and molecular prognostication status of the primary tumor can guide radiological interpretation of hepatic lesions.

Entities:  

Keywords:  Hepatic cyst; Hepatic hemangioma; Liver imaging; Metastasis; Uveal melanoma

Year:  2018        PMID: 30643771      PMCID: PMC6322083          DOI: 10.1159/000485424

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  41 in total

1.  Liver biopsy:complications and risk factors.

Authors:  Pornpen Thampanitchawong; Teerha Piratvisuth
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.

Authors:  Marie Diener-West; Sandra M Reynolds; Donna J Agugliaro; Robert Caldwell; Kristi Cumming; John D Earle; Barbara S Hawkins; James A Hayman; Ishmael Jaiyesimi; Lee M Jampol; John M Kirkwood; Wui-Jin Koh; Dennis M Robertson; John M Shaw; Bradley R Straatsma; Jonni Thoma
Journal:  Arch Ophthalmol       Date:  2005-12

3.  Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement.

Authors:  R C Semelka; D R Martin; C Balci; T Lance
Journal:  J Magn Reson Imaging       Date:  2001-03       Impact factor: 4.813

Review 4.  Imaging of malignant liver masses: characterization and detection.

Authors:  Hyun-Jung Jang; Tae Kyoung Kim; Stephanie R Wilson
Journal:  Ultrasound Q       Date:  2006-03       Impact factor: 1.657

5.  Screening for metastatic malignant melanoma of the uvea revisited.

Authors:  S Eskelin; S Pyrhönen; P Summanen; J U Prause; T Kivelä
Journal:  Cancer       Date:  1999-03-01       Impact factor: 6.860

6.  Whole body PET/CT for initial staging of choroidal melanoma.

Authors:  P T Finger; M Kurli; S Reddy; L B Tena; A C Pavlick
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

7.  Imaging of atypical hemangiomas of the liver with pathologic correlation.

Authors:  V Vilgrain; L Boulos; M P Vullierme; A Denys; B Terris; Y Menu
Journal:  Radiographics       Date:  2000 Mar-Apr       Impact factor: 5.333

8.  Cystic focal liver lesions in the adult: differential CT and MR imaging features.

Authors:  K J Mortelé; P R Ros
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

9.  High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia.

Authors:  Elisabetta Buscarini; Cesare Danesino; Henry Plauchu; Cristina de Fazio; Carla Olivieri; Gianfranco Brambilla; Fernanda Menozzi; Luigi Reduzzi; Pasquale Blotta; Pietro Gazzaniga; Fabio Pagella; Maurizio Grosso; Giacomo Pongiglione; Johnny Cappiello; Alessandro Zambelli
Journal:  Ultrasound Med Biol       Date:  2004-09       Impact factor: 2.998

10.  Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23.

Authors:  Marie Diener-West; Sandra M Reynolds; Donna J Agugliaro; Robert Caldwell; Kristi Cumming; John D Earle; Donna L Green; Barbara S Hawkins; James Hayman; Ishmael Jaiyesimi; John M Kirkwood; Wui-Jin Koh; Dennis M Robertson; John M Shaw; Jonni Thoma
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

View more
  5 in total

Review 1.  Consensus statement for metastatic surveillance of uveal melanoma in Scotland.

Authors:  Vikas Chadha; Paul Cauchi; Wilma Kincaid; Ashita Waterston; Stefano Schipani; Sachin Salvi; Oliver Cram; Diana Ritchie
Journal:  Eye (Lond)       Date:  2022-08-09       Impact factor: 4.456

2.  Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma.

Authors:  Antonio Piñeiro Ces; Manuel Bande Rodriguez; Javier Mosquero Sueiro; Ana María Carballo Castro; Ramón Lobato Busto; Paula Silva Rodriguez; María Pardo Pérez; Francisco Ruiz Oliva-Ruiz; Maria Jose Blanco Teijeiro
Journal:  J Contemp Brachytherapy       Date:  2021-04-14

Review 3.  Application of Multimodal and Molecular Imaging Techniques in the Detection of Choroidal Melanomas.

Authors:  Xuying Li; Lixiang Wang; Li Zhang; Fei Tang; Xin Wei
Journal:  Front Oncol       Date:  2021-02-01       Impact factor: 6.244

4.  Efficacy and Safety of Immune Checkpoint Blockades in the Treatment of Ocular Melanoma: A Systematic Review and Meta-Analysis.

Authors:  Lu Zhao; Wenwen Xia; Yan Zhang; Peng Zou; Qiwen Zhu; Rong Zhang
Journal:  Front Oncol       Date:  2021-12-06       Impact factor: 6.244

5.  Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling.

Authors:  Amy C Schefler; Alison Skalet; Scott Cn Oliver; John Mason; Anthony B Daniels; Katherina M Alsina; Kristen M Plasseraud; Federico A Monzon; Brian Firestone
Journal:  Melanoma Manag       Date:  2020-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.